ICSI & Male factor

ICSI is the single most important advancement in reproductive technology in the past decade due to its ability to completely alleviate male infertility and its diagnostic significance with regard to egg maturity. The first case published was in 1992 for a case with severe male factor that can not be solved with IVF. Since then make factor problems has changed completely.

Intracytoplasmic Sperm Injection is a technique that allows the selection of a single sperm, based on limited morphological criteria for normalcy, and the injection of that sperm into the cytoplasm of a mature egg. The procedure benefits couples where the male has lower than normal sperm numbers and, or abnormal sperm morphology, or even with the absence of sperms in the semen and where the female has abnormal egg morphology, with questions regarding egg maturity from previous IVF cycles. Moreover, ICSI benefits couples when previous IVF cycles have yielded less than a 50% fertilization rate.

Intracytoplasmic Sperm Injection (ICSI) provides help for men with severe sperm dysfunction. In this procedure, a single sperm is micromanipulated and captured in a glass needle and is injected directly into the egg.

Read more about male factor

Male Factor TESE

Testicular Sperm Extraction (TESE) is the process of removing a small portion of tissue from the testicle under local anesthesia and extracting the few viable sperm cells present in that tissue for the purpose of ICSI. TESE is recommended to men who are unable to produce sperm by ejaculation as a result of primary testicular failure, congenital absence of the vase deferens or problems within the transporting male system.

Read more about ICSI & Testicular biopsy for azoospermia (absence of sperm in semen)